Protiva Biotherapeutics Completes $3.5 Million Financing

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Jul 5, 2007 -- Protiva Biotherapeutics Inc. announced today the completion of a convertible debenture financing with commitments of CAD$3.5 million. This fourth round of financing brings Protiva's cumulative venture capital financing to CAD$26.2 million.

Back to news